Stockreport

IMUNON to Host R&D Day on September 18th

Imunon, Inc.  (IMNN) 
PDF R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders, OVATION 2 Study Investigators, and [Read more]